[Chinese expert consensus on the diagnosis and management of older patients with immune thrombocytopenia (2026 edition)].

Authors

Platelet Group, Hematology Subcommittee, Chinese Geriatric Society, Hematology Subcommittee, China International Exchange and Promotive Association for Medical and Health Care

Published in

Zhonghua nei ke za zhi. Volume 65. Issue 10. Pages 1051-1058. Oct 01, 2026.

Abstract

Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder characterized by isolated thrombocytopenia. With the accelerating aging of the global population, the incidence of ITP among older adults (≥60 years) is increasing, and this population exhibits distinct epidemiological features, pathogenic mechanisms, and clinical management needs. To standardize the diagnosis and management of ITP in older adults in China, the Platelet Group of the Hematology Subcommittee of the Chinese Geriatric Society and the Hematology Subcommittee of the China International Exchange and Promotive Association for Medical and Health Care jointly established an expert consensus committee on ITP in older adults. This consensus was developed to integrate evidence-based medical data from the literature with clinical practice experience, provide practical recommendations for standardized diagnosis and treatment of geriatric ITP, and promote the conduct of future clinical research specifically targeting this population.

PMID:
42855751
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.